dCellVax / Regen BioPharma - LARVOL DELTA

Regen BioPharma discovers potential new way to improve outcomes from cancer surgery using combination of cannabidiol and NR2F6 inhibition (PRNewswire) - "Regen BioPharma Inc...announced today data demonstrating its unique combination of NR2F6 inhibition together with cannabidiol decreases cancer metastasis in an animal model of cancer surgery. These experiments are an extension of data disclosed last week[1], in which the combination of NR2F6 suppression and cannabidiol was shown to stimulate dendritic cells, a clinically used immunological cell[2], that coordinates several aspects of the immune system[3]."

Preclinical